Market revenue in 2022 | USD 443.9 million |
Market revenue in 2030 | USD 740.7 million |
Growth rate | 6.6% (CAGR from 2022 to 2030) |
Largest segment | Evaporative dry eye syndrome |
Fastest growing segment | Evaporative Dry Eye Syndrome |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Evaporative Dry Eye Syndrome, Aqueous Deficient Dry Eye Syndrome |
Key market players worldwide | Novartis AG ADR, AbbVie Inc, Sun Pharmaceutical Industries, Santen Pharmaceutical Co Ltd, Johnson & Johnson, Otsuka Pharmaceutical, OASIS Medical, Bausch & Lomb Corp, AFT Pharmaceuticals, Oyster Point Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye syndrome treatment market will help companies and investors design strategic landscapes.
Evaporative dry eye syndrome was the largest segment with a revenue share of 82.72% in 2022. Horizon Databook has segmented the Germany dry eye syndrome treatment market based on evaporative dry eye syndrome, aqueous deficient dry eye syndrome covering the revenue growth of each sub-segment from 2018 to 2030.
Rapidly aging population, rising demand for personalized medicines, and growing prevalence of chronic conditions are expected to accelerate pharmaceutical R&D in the country. According to the estimates published by Office for National Statistics, the population over the age of 85 years is likely to account for 4.3% of the total UK population by 2045.
Owing to these favorable conditions, the UK’s pharmaceutical sector is likely to reach USD 25.58 billion by 2023, registering an estimated annual growth of 3.6% during 2018-2023. Moreover, increasing prevalence of eye-related diseases in Germany is boosting the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany dry eye syndrome treatment market , including forecasts for subscribers. This country databook contains high-level insights into Germany dry eye syndrome treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account